 Product Search |
|
| Input Product Name Or Cas No. |
| Category |
| Products |
 1,1-Dimethylethyl N-[1-[6-chloro-3-(3,5- |
| tert-butyl (1-(3-chloro-6-(3-cyano-2-(me |
| 1,1,2,2,3,3,4,4-Octafluoro-1,4-butanedis |
| 1,1-Difluoromethanedisulfonyl difluoride |
| 1,1,2,2,3,3,4,4,5,5-Decafluoro-1,5-penta |
| 1-Chloro-4-[2-(chloromethyl)-5,5-dimethy |
| 1-Chloro-4-[2-(chloromethyl)-4,4-dimethy |
| 3-Fluoro-5-nitro-4-[[(tetrahydro-2H-pyra |
| 3-Fluoro-5-nitro-4-[[[1-(3-oxetanyl)-4-p |
| 3-Fluoro-5-nitro-4-[(4-piperidinylmethyl |
| 1,1-Dimethylethyl 4-[[[4-(aminosulfonyl) |
| 4-Fluoro-2-(1H-pyrrolo[2,3-b]pyridin-5-y |
| 7,7-Dimethyl-8-methylene-1,4-dioxaspiro[ |
| 7,7,8,8-Tetramethyl-1,4-dioxaspiro[4.5]d |
| 1-Chloro-4-[2-(chloromethyl)-4,4,5,5-tet |
| N-[4-(2-Methoxyacetyl)-2-nitrophenyl]ace |
| Ethanone, 1-(4-aminophenyl)-2-methoxy- |
| N-[6-Chloro-5-[2-(dimethylamino)ethenyl] |
| tri-p-tolylsulfonium 2-((adamantane-1-ca |
| Benzene, 1-[3,3-dimethyl-1-[(trimethylsi |
| (4-methoxyphenyl)diphenylsulfonium 2,4,6 |
| bis(4-(tert-butyl)phenyl)iodonium 2-(ada |
| 4-(4-(tert-butyl)phenyl)-1,4-oxathian-4- |
| (4-(cyclohexylsulfonyl)phenyl)diphenylsu |
| mono(triphenylsulfonium) mono((2,2,3,3,4 |
| mono(tris(3-methoxyphenyl)sulfonium) mon |
| 4-(4-(tert-butyl)phenyl)-1,4-oxathian-4- |
| 1-(4-Methoxyphenyl)-3,3-dimethyl-1-butan |
| 1-(9,10-Dihydro-9,10-dioxo-2-anthracenyl |
| 2-Propanol, 1,1′-[9H-fluoren-9-ylidene |
| 1,1′-[9H-Fluoren-9-ylidenebis[6,2-naph |
| 1,1′-[9H-Fluoren-9-ylidenebis(6,2-naph |
| 3′,6′-Bis(2-oxiranylmethoxy)spiro[9H |
| 2,2′-[9H-Fluoren-9-ylidenebis(6,2-naph |
| 1,1′-[9H-Fluoren-9-ylidenebis([1,1′- |
| Ethanol, 2,2′-[spiro[9H-fluorene-9,9 |
| Oxirane, 2,2′-[9H-fluoren-9-ylidenebis |
| 3,3,3-Trifluoropropyl 2,2-difluoro-3-[(2 |
| (2-bromoadamantan-1-yl)methanol |
| 3-(4-Formylphenoxy)benzaldehyde |
| 2-(2,5-dioxopyrrolidin-1-yl)ethyl acryla |
| 3-Ethyl-3-[[(2-methyl-2-oxiranyl)methoxy |
| 2-methyladamantane-1-carboxylic acid |
| (3-ethyl-1,5-dioxaspiro[5.5]undecan-3-yl |
| (5-Ethyl-2-methyl-2-phenyl-1,3-dioxan-5- |
| 2-((((2-isopropyladamantan-2-yl)oxy)carb |
| 2-((((2-ethyladamantan-2-yl)oxy)carbonyl |
| 2-((((2-methyladamantan-2-yl)oxy)carbony |
| 2-(Hexahydro-2-oxo-3,5-methano-2H-cyclop |
| 1,1-Dimethylethyl 4-[4-fluoro-3-(methoxy |
|
| Products |
| Catalogue Number |
Products |
CAS No. |
Assay |
| RovathinS31419 | 2-(R)-Carboxymethylpyrrolidine-1-carboxylic acid tert-butyl ester | 101555-60-6 | 95% |
| RovathinS31420 | Benzoxazole, 2-(3-piperidinyl)-, hydrochloride | 51785-15-0 | 95% |
| RovathinS31421 | Benzoxazole, 2-(3-piperidinyl)- | 754126-86-8 | 95% |
| RovathinS31422 | Anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone, 5,12-dimethoxy-2,9-dimethyl- | 1119720-67-0 | 96% |
| RovathinS31423 | [1,2,4]Triazolo[1,5-c]quinazolin-5(6H)-one, 9-bromo- | 882517-92-2 | 96% |
| RovathinS31424 | 4-(Diethylamino)benzaldehyde N,N-diphenylhydrazone | 68189-23-1 | 95% |
| RovathinS31425 | Pentanamide, 2-[[(4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoro-, (2R)- | 1146699-66-2 | 95% |
| RovathinS31426 | Carbamic acid, N-[2-[(R)-(3-chlorophenyl)[(3R)-1-[[[(2S)-2-(methylamino)-3-[(3R)-tetrahydro-2H-pyran-3-yl]propyl]amino]carbonyl]-3-piperidinyl]methoxy]ethyl]-, methyl ester, 2,2,2-trifluoroacetate | 1013937-63-7 | 95% |
| RovathinS31427 | Carbamic acid, N-[2-[(R)-(3-chlorophenyl)[(3R)-1-[[[(2S)-2-(methylamino)-3-[(3R)-tetrahydro-2H-pyran-3-yl]propyl]amino]carbonyl]-3-piperidinyl]methoxy]ethyl]-, methyl ester | 942142-51-0 | 95% |
| RovathinS31428 | Cyclopentanecarboxylic acid, 2-[[4'-[[(phenylamino)carbonyl]amino][1,1'-biphenyl]-4-yl]carbonyl]-, (1R,2R)- | 959122-11-3 | 95% |
| RovathinS31429 | Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]- | 571190-30-2 | 95% |
| RovathinS31430 | Solifenacin succinate | 242478-38-2 | 95% |
| RovathinS31431 | Benzeneacetamide, N-[(1S)-2-[[(7S)-6,7-dihydro-5-methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluoro-α-hydroxy-, (αS)- | 209984-57-6 | 95% |
| RovathinS31432 | 1-Piperidinebutanoic acid, 4-[(S)-(4-chlorophenyl)-2-pyridinylmethoxy]-, benzenesulfonate | 190786-44-8 | 95% |
| RovathinS31433 | 2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-, ethyl ester, (1S)- | 180468-42-2 | 95% |
| RovathinS31434 | 3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-, hydrobromide (1:1), (3S)- | 133099-07-7 | 95% |
| RovathinS31435 | 3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-,(3S)- | 133099-04-4 | 95% |
| RovathinS31436 | 1-Naphthalenol, 5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-, hydrochloride (1:1), (6S)- | 125572-93-2 | 95% |
| RovathinS31437 | 1-Naphthalenol, 5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-,(6S)- | 99755-59-6 | 95% |
| RovathinS31438 | Spiro[1-azabicyclo[2.2.2]octane-3,5'-[1,3]oxathiolane], 2'-methyl-, (2'R,3R)-rel- | 107233-08-9 | 95% |
| RovathinS31439 | Imidazo[4,5-d][1,3]diazepin-8(3H)-one, 4,7-dihydro- | 72079-77-7 | 95% |
| RovathinS31440 | 2(1H)-Pyrimidinone, 4-amino-1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodo- | 69123-90-6 | 95% |
| RovathinS31441 | 2-Naphthalenamine, 1,2,3,4-tetrahydro-5-methoxy-, hydrochloride (1:1), (2S)- | 58349-17-0 | 95% |
| RovathinS31442 | 2-Naphthalenamine, 1,2,3,4-tetrahydro-5-methoxy-,(2S)- | 105086-80-4 | 95% |
| RovathinS31443 | Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (8R)- | 53910-25-1 | 95% |
| RovathinS31444 | 6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-one, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aR,8aR)-rel- | 1668-86-6 | 95% |
| RovathinS31445 | 4H-Azepin-4-one, hexahydro-1-(phenylmethyl)- | 1208-75-9 | 95% |
| RovathinS31446 | 6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-one, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,8aS)- | 510-77-0 | 95% |
| RovathinS31447 | 1H-Pyrazolo[4,3-d]pyrimidine-3-carboxylic acid, 5,7-dichloro-, ethyl ester | 1053656-63-5 | 95% |
| RovathinS31448 | 1H-Pyrazolo[4,3-d]pyrimidine, 5,7-dichloro-1-methyl- | 939979-32-5 | 95% |
|
|
|
|
